Navigation Links
Isis Reports Financial Results and Highlights for First Quarter of 2008
Date:5/12/2008

ompany has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

This press release includes forward-looking statements regarding Isis Pharmaceuticals' business, the financial position and outlook for Isis as well as its Ibis Biosciences subsidiary and its Regulus joint venture, and the therapeutic and commercial potential of the Company's technologies and products in development. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals or projections. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, in developing and commercializing systems to identify infectious organisms that are effective and commercially attractive, and in the endeavor of building a business around such products. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Over 700 doctors, nutritionists, nurses, and ... the secretaries of the U.S. Department of Agriculture and ... them to embrace the 2015 Dietary Guidelines Advisory Committee’s ... human health, economic prosperity, and our nation’s food security. ... letter, including: Dr. David Katz, founding director of the ...
(Date:5/26/2015)... The American College of Traditional Chinese Medicine ... Open House/Free Application Day on Wednesday, July 22. The event ... and will be held at ACTCM Pioneer Square, located at ... in, attendees will be greeted with an introduction and welcome ... campus at 11:45 a.m. Lunch will be served at noon, ...
(Date:5/26/2015)... Irwin Gross, M.D., Accumen, Inc.’s ... Blood Management (PBM) initiative at Eastern Maine Medical Center ... more than 60 percent and improved patient outcomes over ... an article in the May 2015 edition of Transfusion, ... cell loss, less acute kidney injury and cut the ...
(Date:5/26/2015)... On May 26, 2015, My Positive Perspective host Jason ... Windfall. At the start of the episode, Deierlein asks Windfall, ... characteristics with it, so could you tell people how you ... was reading the newspaper looking for a job when I ... a person with hustle. I responded to the ad and ...
(Date:5/26/2015)... May 26, 2015 Pasadena porcelain ... complimentary dental cleanings with cosmetic treatments. Cosmetic dentistry is ... Cosmetic Dentistry , “We are committed to providing you ... technology, outstanding customer service and a smile of a ... change your smiles but to change your life,” explains ...
Breaking Medicine News(10 mins):Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 2Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 3Health News:ACTCM to Host Summer Open House 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:My Positive Perspective Broadcasts Episode with Oceans 6 to Discuss Their Role in Helping the Community 2Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2
... Pa., March 3 Genaera Corporation (Nasdaq: GENR ) ... December 31, 2008. The net loss for the year ended December ... diluted, as compared to a net loss of $15.7 million, or ... 31, 2007. The net loss for the quarter ended December 31, ...
... Doctors urge all levels of society to encourage good eating ... -- Every level of society must contribute to strategies meant ... diet, according to the American Heart Association. , "Health ... put on their plates to outside influences and trends in ...
... Automate Health Care in Master-Planned CommunitiesSCOTTSDALE, Ariz., March 3 ... across the West but it,s his company,s ideas that ... alter the use of energy grids. And now ... this week to The Wall Street Journal,s Second Annual ...
... Conference March 5 at 11 a.m. in Richmond RICHMOND, ... Virginia will hold a press conference on March 5 in ... Warner and the entire Virginia Congressional Delegation to support legislation ... authority over tobacco products. The House Energy and Commerce ...
... day could increase a person,s risk of pancreatic cancer ... Cancer Epidemiology, Biomarkers and Prevention , a journal ... "Our findings support multiple nutrition recommendations that men should ... per day and women should limit intake to no ...
... new study provides insight into how a short burst in ... it from stress and assaults such as heart attacks. In ... at Boston University School of Medicine have demonstrated for the ... simple anion are sufficient to have a lasting impact on ...
Cached Medicine News:Health News:Genaera Corporation Announces 2008 Financial Results 2Health News:Genaera Corporation Announces 2008 Financial Results 3Health News:Genaera Corporation Announces 2008 Financial Results 4Health News:Genaera Corporation Announces 2008 Financial Results 5Health News:U.S. Diet Needs Heart-Felt Overhaul 2Health News:Innovative Plans by Major Arizona-Based Developer Sparks Landmark Energy Conservation Legislation in Multiple States to Urge Federal Action at Wall Street Journal Conference This Week with Gore, Google CEO & T. Boone Pickens 2Health News:Virginia Faith Leaders Call on Sens. Webb & Warner to Support Legislation to Protect Kids From Tobacco 2Health News:New study shows how spikes in nitrite can have 2Health News:New study shows how spikes in nitrite can have 3
(Date:5/26/2015)... 26, 2015  PAREXEL International Corporation (NASDAQ: PRXL ... the Goldman Sachs Healthcare Conference in Palos Verdes, CA.  ... Officer, will be making a presentation on PAREXEL and ... June 9, 2015. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
(Date:5/26/2015)... 26, 2015 Cellular testing ... ,What,s the future of technologies for screening cells? ... 2015. Stay ahead there for data, benefiting your ... results, R&D, opportunities and revenue forecasts. ... you what,s possible for cell-based assays ...
(Date:5/26/2015)... -- ViiV Healthcare, Aurobindo Pharma, and the ... Aurobindo Pharma has submitted an Abbreviated New Drug Application ... Food and Drug Administration (FDA), for the treatment of ... version of dolutegravir, less than two years after FDA ... the United States . Upon receiving ...
Breaking Medicine Technology:PAREXEL International To Present At Goldman Sachs Healthcare Conference 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7
...   Prasco® Laboratories announced today it has entered into ... ) for the distribution in the U.S. of ... (Carbamazepine) Extended-Release Capsules in 100 mg, 200 mg and ... are AB-rated, therapeutically equivalent and substitutable for the brand ...
... 2012  The Board of Directors of MiMedx Group, Inc. (OTCBB: ... supports the Company,s Chairman and CEO, Parker H. "Pete" ... Exchange Commission ("SEC"). The SEC has ... in 2007, when he was Chairman and CEO of ...
Cached Medicine Technology:Prasco® Launches Authorized Generic of Shire's Carbatrol® 2Prasco® Launches Authorized Generic of Shire's Carbatrol® 3Prasco® Launches Authorized Generic of Shire's Carbatrol® 4MiMedx Group, Inc. Board Announces Support for Chairman Parker H. "Pete" Petit 2
Cold light source triple outlet....
Cold light source single outlet....
The 9100 is a truly affordable 100 Watt xenon light source providing accurate color and brightness. This xenon light source is ideal for surgery centers, evaluations or general office use....
The Carl Zeiss Head-worn Loupes L and LC are the ideal solution if a low magnification suffices for your work and you want to keep your hands free to perform the task at hand....
Medicine Products: